Publication | Closed Access

A novel monoclonal antibody specific to the C-terminal tail of the gp41 envelope transmembrane protein of human immunodeficiency virus type 1 that preferentially neutralizes virus after it has attached to the target cell and inhibits the production of infectious progeny

MedicineC-terminal TailHuman RetrovirusImmunologyAntiviral ResponseMolecular BiologyVirologyAntibody EngineeringHivImmunotherapyNovel Monoclonal AntibodyViral Structural ProteinInfectious Progeny